{{Drugbox
| Verifiedfields = changed
| verifiedrevid = 477166277
| IUPAC_name = 3-(bicyclo[2.2.1]hept-5-en-2-yl)-6-chloro-3,4-dihydro-2''H''-1,2,4-benzothiadiazine-7-sulfonamide 1,1-dioxide
| image = Cyclothiazide.png
<!--Clinical data-->
| tradename =  
| pregnancy_category =  
| legal_status = Rx-only
| routes_of_administration =  
<!--Pharmacokinetic data-->
| bioavailability =  
| metabolism =  
| elimination_half-life =  
| excretion =  
<!--Identifiers-->
| IUPHAR_ligand = 4167
| CAS_number_Ref = {{cascite|correct|??}}
| CAS_number = 2259-96-3
| ATC_prefix = C03
| ATC_suffix = AA09
| PubChem = 2910
| DrugBank_Ref = {{drugbankcite|changed|drugbank}}
| DrugBank = DB00606
| ChemSpiderID_Ref = {{chemspidercite|changed|chemspider}}
| ChemSpiderID = 4535011
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = P71U09G5BW
| KEGG_Ref = {{keggcite|correct|kegg}}
| KEGG = D01256
| ChEMBL_Ref = {{ebicite|changed|EBI}}
| ChEMBL = 61593
<!--Chemical data-->
| C=14 | H=16 | Cl=1 | N=3 | O=4 | S=2
| molecular_weight = 389.88 g/mol
| smiles = O=S(=O)(c1c(Cl)cc2c(c1)S(=O)(=O)NC(N2)C4[C@@H]3\C=C/[C@@H](C3)C4)N
| StdInChI_Ref = {{stdinchicite|changed|chemspider}}
| StdInChI = 1S/C14H16ClN3O4S2/c15-10-5-11-13(6-12(10)23(16,19)20)24(21,22)18-14(17-11)9-4-7-1-2-8(9)3-7/h1-2,5-9,14,17-18H,3-4H2,(H2,16,19,20)/t7-,8+,9?,14?/m0/s1
| StdInChIKey_Ref = {{stdinchicite|changed|chemspider}}
| StdInChIKey = BOCUKUHCLICSIY-QJWLJZLASA-N
}}

'''Cyclothiazide''' ('''Anhydron''', '''Acquirel''', '''Doburil''', '''Fluidil''', '''Renazide''', '''Tensodiural''', '''Valmiran''') is a [[benzothiadiazide]] ([[thiazide]]) [[diuretic]] and [[antihypertensive]] that was originally introduced in the [[United States]] in 1963 by [[Eli Lilly and Company|Eli Lilly]] and was subsequently also marketed in [[Europe]] and [[Japan]].<ref name="isbn3-88763-075-0">{{cite book | author = Swiss Pharmaceutical Society | title = Index Nominum 2000: International Drug Directory (Book with CD-ROM) | publisher = Medpharm Scientific Publishers | location = Boca Raton | year = 2000 | pages = 1932 | isbn = 3-88763-075-0 | oclc = | doi = | url = https://books.google.com/books?id=5GpcTQD_L2oC&lpg=PA287&dq=Cyclothiazide&pg=PA287#v=onepage&q=Cyclothiazide&f=false}}</ref><ref name="isbn0-8155-1144-2">{{cite book | author = Sittig, Marshall | title = Pharmaceutical manufacturing encyclopedia | publisher = Noyes Publications | location = Park Ridge, N.J., U.S.A | year = 1988 | pages = 1756 | isbn = 0-8155-1144-2 | oclc = | doi = | url = https://books.google.com/books?id=X2EyLsG4bcUC&lpg=PA418&dq=Cyclothiazide&pg=PA418#v=onepage&q&f=false}}</ref> Related [[drug]]s include [[diazoxide]], [[hydrochlorothiazide]], and [[chlorothiazide]].<ref name="isbn0-8493-8307-2">{{cite book |author1=Skolnick, Phil |author2=Palfreyman, Michael G. |author3=Reynolds, Ian J. | title = Direct and allosteric control of glutamate receptors | publisher = CRC Press | location = Boca Raton | year = 1994 | pages = 174 | isbn = 0-8493-8307-2 | oclc = | doi = | url = https://books.google.com/books?id=Fp9RLJTt7NkC&lpg=PA34&dq=Cyclothiazide&pg=PA65#v=onepage&q=Cyclothiazide&f=false}}</ref>

In 1993, it was discovered that cyclothiazide is a [[positive allosteric modulator]] of the [[AMPA receptor|AMPA]] and [[kainate receptor]]s, capable of reducing or essentially eliminating rapid [[desensitization (medicine)|desensitization]] of the former receptor, and potentiating AMPA-mediated [[glutamate]] currents by as much as 18-fold at the highest concentration tested (100 [[micromolar|μM]]).<ref name="isbn0-8493-8307-2"/><ref name="pmid8103555">{{cite journal |vauthors=Yamada KA, Tang CM | title = Benzothiadiazides inhibit rapid glutamate receptor desensitization and enhance glutamatergic synaptic currents | journal = Journal of Neuroscience | volume = 13 | issue = 9 | pages = 3904–15 |date=September 1993 | pmid = 8103555 | doi = | url = http://www.jneurosci.org/cgi/pmidlookup?view=long&pmid=8103555}}</ref><ref name="pmid7915948">{{cite journal  |vauthors=Bertolino M, Baraldi M, Parenti C, etal | title = Modulation of AMPA/kainate receptors by analogues of diazoxide and cyclothiazide in thin slices of rat hippocampus | journal = Receptors & Channels | volume = 1 | issue = 4 | pages = 267–78 | year = 1993 | pmid = 7915948 | doi = | url = }}</ref><ref name="isbn3-540-22568-4">{{cite book |author1=Ströhle, Andreas |author2=Bilkei-Gorzo, A. |author3=Holsboer, Florian | title = Anxiety and anxiolytic drugs | publisher = Springer | location = Berlin | year = 2005 | pages = 566 | isbn = 3-540-22568-4 | oclc = | doi = | url = https://books.google.com/books?id=RDP4_sBnsl4C&lpg=PA255&dq=Cyclothiazide&pg=PA256#v=onepage&q=Cyclothiazide&f=false}}</ref> Additionally, in 2003, cyclothiazide was also found to act as a [[GABAA receptor|GABA<sub>A</sub> receptor]] [[negative allosteric modulator]], potently inhibiting GABA<sub>A</sub>-mediated currents.<ref name="pmid14534329">{{cite journal |vauthors=Deng L, Chen G | title = Cyclothiazide potently inhibits gamma-aminobutyric acid type A receptors in addition to enhancing glutamate responses | journal = Proceedings of the National Academy of Sciences of the United States of America | volume = 100 | issue = 22 | pages = 13025–9 |date=October 2003 | pmid = 14534329 | pmc = 240738 | doi = 10.1073/pnas.2133370100 | url = http://www.pnas.org/cgi/pmidlookup?view=long&pmid=14534329}}</ref> In animals it is a powerful [[convulsant]], robustly enhancing [[epileptiform]] activity and inducing [[seizure]]s, but without producing any apparent [[neurotoxicity|neuronal death]].<ref name="pmid16423850">{{cite journal |vauthors=Qi J, Wang Y, Jiang M, Warren P, Chen G | title = Cyclothiazide induces robust epileptiform activity in rat hippocampal neurons both in vitro and in vivo | journal = The Journal of Physiology | volume = 571 | issue = Pt 3 | pages = 605–18 |date=March 2006 | pmid = 16423850 | pmc = 1805799 | doi = 10.1113/jphysiol.2005.103812 | url = http://www.jphysiol.org/cgi/pmidlookup?view=long&pmid=16423850}}</ref><ref name="pmid20678492">{{cite journal |vauthors=Kong S, Qian B, Liu J, Fan M, Chen G, Wang Y | title = Cyclothiazide induces seizure behavior in freely moving rats | journal = Brain Research | volume = 1355| issue = | pages = 207–213|date=July 2010 | pmid = 20678492 | doi = 10.1016/j.brainres.2010.07.088 | url = http://linkinghub.elsevier.com/retrieve/pii/S0006-8993(10)01678-1 | pmc = 2947190}}</ref>

Cyclothiazide has been found to act as a [[non-competitive antagonist]] of the [[mGluR1]].<ref name="pmid17095021">{{cite journal | vauthors = Surin A, Pshenichkin S, Grajkowska E, Surina E, Wroblewski JT | title = Cyclothiazide selectively inhibits mGluR1 receptors interacting with a common allosteric site for non-competitive antagonists | journal = Neuropharmacology | volume = 52 | issue = 3 | pages = 744–54 | year = 2007 | pmid = 17095021 | pmc = 1876747 | doi = 10.1016/j.neuropharm.2006.09.018 | url = }}</ref> It is selective for mGluR1 over other [[metabotropic glutamate receptor]]s.<ref name="pmid17095021" />

==Synthesis==
[[File:Cyclothiazide synthesis.svg|thumb|center|700px|Cyclothiazide synthesis:<ref>{{Cite journal | doi = 10.1021/jo01066a046| title = Diuretics. V. 3,4-Dihydro-1,2,4-benzothiadiazine 1,1-Dioxides| journal = The Journal of Organic Chemistry| volume = 26| issue = 8| pages = 2814| year = 1961| last1 = Whitehead | first1 = C. W. | last2 = Traverso | first2 = J. J. | last3 = Sullivan | first3 = H. R. | last4 = Marshall | first4 = F. J. }}</ref> E. Müller, K. Hasspacher, {{US patent|3275625}} (1966 to [[Boehringer Ingelheim]]).]]

==See also==
* [[AMPA receptor positive allosteric modulator]]

==References==
{{Reflist|30em}}

{{Diuretics}}
{{Navboxes
| title = [[Pharmacodynamics]]
| titlestyle = background:#ccccff
| list1 = 
{{GABAA receptor modulators}}
{{Glutamate receptor modulators}}
}}

[[Category:Diuretics]]
[[Category:Sulfonamides]]
[[Category:AMPA receptor positive allosteric modulators]]
[[Category:Kainate receptor agonists]]
[[Category:Benzothiadiazines]]
[[Category:Chloroarenes]]
[[Category:GABAA receptor negative allosteric modulators]]
[[Category:Carbonic anhydrase inhibitors]]
[[Category:Convulsants]]
[[Category:MGlu1 receptor antagonists]]
[[Category:Alkene derivatives]]